ResearcherUniversity of VeronaActive in the last 2 years
Marzia Tripepi
Matched on ORCID iD 0000-0002-2233-0903; OpenAlex author ID A5033041175. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2023: 3 papers · 2024: 1 paper
Papers 4
- Impact of neoadjuvant chemoradiotherapy on pathologic response in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Co-author DOI 10.1016/j.pan.2024.09.010↗
- Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2023.02.005↗
- Telemedicine and Pancreatic Cancer: A Systematic Review. Co-author DOI 10.1089/tmj.2022.0140↗
- Co-design, co-learning, and co-production of an app for pancreatic cancer patients-the "Pancreas Plus" study protocol. Co-author DOI 10.21037/mhealth-22-48↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Giovanni Butturini · 4 shared papers, 2023–2024 · strength 0.82
- Paper Co-design, co-learning, and co-production of an app for pancreatic cancer patients-the "Pancreas Plus" study protocol. DOI 10.21037/mhealth-22-48↗
- Paper Telemedicine and Pancreatic Cancer: A Systematic Review. DOI 10.1089/tmj.2022.0140↗
- Paper Impact of neoadjuvant chemoradiotherapy on pathologic response in pancreatic ductal adenocarcinoma: A systematic review… DOI 10.1016/j.pan.2024.09.010↗
- Isabella M. Frigerio · 3 shared papers, 2023–2024 · strength 0.58
- Paper Telemedicine and Pancreatic Cancer: A Systematic Review. DOI 10.1089/tmj.2022.0140↗
- Paper Impact of neoadjuvant chemoradiotherapy on pathologic response in pancreatic ductal adenocarcinoma: A systematic review… DOI 10.1016/j.pan.2024.09.010↗
- Paper Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal aden… DOI 10.1016/j.pan.2023.02.005↗
- Erica Pizzocaro · 2 shared papers, 2023 · strength 0.46
- Alessandro Giardino · 2 shared papers, 2023 · strength 0.38
- Gaya Spolverato · 2 shared papers, 2023–2024 · strength 0.36
- Paper Impact of neoadjuvant chemoradiotherapy on pathologic response in pancreatic ductal adenocarcinoma: A systematic review… DOI 10.1016/j.pan.2024.09.010↗
- Paper Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal aden… DOI 10.1016/j.pan.2023.02.005↗
- Quoc Riccardo Bao · 2 shared papers, 2023–2024 · strength 0.36
- Paper Impact of neoadjuvant chemoradiotherapy on pathologic response in pancreatic ductal adenocarcinoma: A systematic review… DOI 10.1016/j.pan.2024.09.010↗
- Paper Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal aden… DOI 10.1016/j.pan.2023.02.005↗
- Francesca Dal Mas · 1 shared paper, 2023 · strength 0.24
- Lorenzo Cobianchi · 1 shared paper, 2023 · strength 0.24
- Marco Ventin · 1 shared paper, 2024 · strength 0.20
- Cristina Rosa Ferrone · 1 shared paper, 2024 · strength 0.20
- Filippo Scopelliti · 1 shared paper, 2023 · strength 0.16
- Paolo Regi · 1 shared paper, 2023 · strength 0.16
- Roberto Girelli · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.